Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "sandoz inc"

Amgen, Inc: How Damaging Will Be Novartis Enbrel Copy
Bidness Etc

Enbrel Biosimilar Approved in US But Enjoined For Now

On August 30 FDA Sandoz Inc.'s biosimilar of Enbrel (etanercept), Amgen Inc.'s blockbuster biologic for treatment of moderate to severe rheumatoid arthritis and a number of other autoimmune conditions. The biosimilar, Erelzi (etanercept-szzs), is ... JD Supra, 4 weeks ago
Amgen Inc. v. Apotex Inc Lexology, 1 month ago
[x]  

TWi Confirms Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Androgel 1.62%

Monday, September 19, 2016 TWi Pharmaceuticals, Inc. confirmed today that it has filed an Abbreviated New Drug Application (ANDA) containing a Paragraph IV certification with US FDA seeking approval to market a generic version of Androgel 1.62%, ...
 Pharma Focus Asia1 week ago
Nasdaq

Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval

Amgen, Inc. AMGN today announced the approval of Amjevita (adalimumab-atto), a biosimilar version to AbbVie Inc.'s ABBV rheumatoid arthritis (RA) drug Humira. Amjevita has been approved for the same indications that Humira is being used for ...
 Yahoo! Singapore4 days ago Humira® Update: Big Guns Take Aim at Top-Selling Biologic  JD Supra1 month ago Coherus Biosciences Inc (CHRS) Has Set Its Sights On Amgen, Inc. (AMGN)  InsiderMonkey.com1 month ago AbbVie Inc, Amgen, Inc: Lengthy Legal Battle Over Humira Begins  Bidness Etc1 month ago
[x]  

Edited Transcript of SELB earnings conference call or presentation 9-Aug-16 12:30pm GMT

Q2 2016 Selecta Biosciences Inc Earnings Call TEXT version of Transcript ================================================================================ Corporate Participants ...
 Yahoo! Finance1 month ago Impax Laboratories (IPXL) George Frederick Wilkinson on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha1 month ago Pernix Therapeutics Holdings (PTX) Q2 2016 Results - Earnings Call Transcript  Seeking Alpha1 month ago Apricus Biosciences' (APRI) CEO Richard Pascoe on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha1 month ago

Novartis Taps Biosimilar Experience in Europe to Snag U.S. Sales

Novartis AG, which just won U.S. approval for a lower-priced version of Amgen Inc.'s blockbuster arthritis drug Enbrel, estimates that the market for copies of biotechnology drugs could grow seven-fold by the end of the decade. The treatment, ...
 Bloomberg4 weeks ago

Fitch Rates Amgen Inc.'s Notes Offering 'BBB'

CHICAGO--( BUSINESS WIRE )--Fitch Ratings has assigned a 'BBB' rating to Amgen's senior unsecured notes offering. The ratings apply to $34.2 billion of debt outstanding at June 30, 2016. A full list of Amgen's ratings can be found at the end of ...
 Business Wire1 month ago Fitch Affirms Amgen Inc.'s IDR at 'BBB'; Outlook Stable  Business Wire1 month ago
[x]  
SPi World News

Apricus Biosciences Announces Completion of Transfer of the Marketing Authorizations for Vitaros ® in Finland and Denmark to Ferring Pharmaceuticals

SAN DIEGO, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Ferring Pharmaceuticals, the Company's new partner in ...
 Stockwatch1 week ago Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Argentina  Pharmaceutical Tech.com3 weeks ago Ferring receives German marketing authorization for erectile dysfunction drug  PredictWallStreet3 weeks ago Health Canada Approves New Indications for PrOmnitrope(R) (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)  SPi World News1 month ago
[x]  

Aequus Pharmaceuticals Inc. (AQSZF: OTCQB) | Aequus Obtains Ontario Provincial Listing for Vistitan(TM)

) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that it has successfully ...
 OTC Markets1 day ago Aequus Obtains Ontario Provincial Listing for Vistitan(TM)  Nasdaq1 day ago AEQUUS PHARMACEUTICALS : Obtains Ontario Provincial Listing for Vistitan(TM)  4 Traders1 day ago
[x]  
Zacks.com

Biosimilars in Limelight on FDA Approval of Amgen Drug

Late last week, the FDA approved yet another biosimilar product -- biotech giant Amgen Inc.'s ( AMGN - Analyst Report ) Amjevita (adalimumab-atto). Amjevita has been approved for use in all eligible indications of the reference product, AbbVie ...
 Zacks.com3 days ago
[x]  
Freshnews.com

Nexus BioPharma, Inc. Appoints Helen Stefanovic as Director of Regulatory Affairs

MONTCLAIR, N.J. , Sept.22, 2016 /PRNewswire/ -- Nexus BioPharma, Inc., ( OTC-BB: NEXS ), a company specializing in the development of a weight loss drug therapy, announced today the appointment ofHelen Stefanovic as Director of Regulatory Affairs.
 BioSpace1 week ago Nexus BioPharma Inc Appoints Helen Stefanovic as Director of Regulatory Affairs  Pharma Focus Asia1 week ago Nexus BioPharma Appoints Helen Stefanovic as Director of Regulatory Affairs  Citybizlist1 week ago Nexus BioPharma, Inc. : Appoints Helen Stefanovic as Director of Regulatory Affairs  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less